Kevin Maclay Speaks to Bloomberg on Purdue Pharma Settlement

Bloomberg Law

Purdue Pharma is poised to wrap up all liability for its role in the opioid crisis in a matter of weeks after its $8.3 billion settlement with the Justice Department cleared the way to resolve outstanding bankruptcy claims.

. . .

A “positive sign,” the agency’s action “shows that the federal government is willing to allow most of the funds that it would have been able to assert a claim to flow into the abatement,” said Kevin Maclay, a lawyer with Caplin & Drysdale who represents more than 1,300 local government entities in the bankruptcy.

For the full article, please visit Bloomberg Law’s website (subscription required).


Related Practices/Industries

Jump to Page

We use cookies to make your experience of our website better. By continuing to browse this site you consent to the use of cookies. Please visit our Privacy Policy for more information.